Eculizumab improves fatigue in refractory generalized myasthenia gravis

被引：0
|
作者：
Henning Andersen
Renato Mantegazza
Jing Jing Wang
Fanny O’Brien
Kaushik Patra
James F. Howard
机构：
[1] Aarhus University Hospital,Department of Neurology
[2] IRCCS,Foundation of the Carlo Besta Neurological Institute
[3] Formerly of Alexion Pharmaceuticals,Department of Neurology, UNC School of Medicine
[4] Inc.,undefined
[5] Alexion Pharmaceuticals,undefined
[6] Inc.,undefined
[7] University of North Carolina at Chapel Hill,undefined
来源：
Quality of Life Research | 2019年 / 28卷
关键词：
Eculizumab; Myasthenia gravis; Fatigue; Neuro-QOL Fatigue; Quality of life; Terminal complement inhibition; Complement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2247 / 2254
页数：7
相关论文
共 50 条
  • [21] Dramatic improvement in refractory myasthenia gravis with eculizumab treatment: a case report
    Kana Ohnari
    Tomoyo Hashimoto
    Yukio Iwanaka
    Keiko Ohnari
    Hiroaki Adachi
    Kazumasa Okada
    [J]. Journal of Neurology, 2024, 271 : 2902 - 2905
  • [22] CLINICAL EXPERIENCE WITH ECULIZUMAB IN TREATMENT-REFRACTORY ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS
    Katyal, Nakul
    Narula, Naureen
    Govindarajan, Raghav
    [J]. MUSCLE & NERVE, 2021, 64 : S9 - S9
  • [23] Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study
    Brandsema, John F.
    Ginsberg, Matthew
    Hoshino, Hideki
    Mimaki, Masakazu
    Nagata, Satoru
    Rao, Vamshi K.
    Ruzhansky, Katherine
    Suresh, Niraja
    Tiongson, Emmanuelle
    Yamanouchi, Hideo
    Frick, Glen
    Hicks, Eden
    Liao, Serena
    Howard, James F.
    [J]. PEDIATRIC NEUROLOGY, 2024, 156 : 198 - 207
  • [24] A Phase 3, Open-Label, Multicenter Study To Evaluate Eculizumab In Adolescents With Refractory Generalized Myasthenia Gravis
    Brandsema, John F.
    Ginsberg, Matthew
    Hoshino, Hideki
    Mimaki, Masakazu
    Nagata, Satoru
    Rao, Vamshi
    Ruzhansky, Katherine
    Suresh, Niraja
    Tiongson, Emmanuelle
    Yamanouchi, Hideo
    Frick, Glen
    Hicks, Eden
    Liao, Serena
    Howard, James
    [J]. NEUROLOGY, 2023, 100 (17)
  • [25] A PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE ECULIZUMAB IN ADOLESCENTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS
    Brandsema, John
    Ginsberg, Matthew
    Hoshino, Hideki
    Mimaki, Masakazu
    Nagata, Satoru
    Rao, Vamshi
    Ruzhansky, Katherine
    Suresh, Niraja
    Tiongson, Emmanuelle
    Yamanouchi, Hideo
    Frick, Glen
    Hicks, Eden
    Liao, Serena
    Howard, James
    [J]. MUSCLE & NERVE, 2022, 66 : S123 - S124
  • [26] Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
    Katyal, Nakul
    Narula, Naureen
    Govindarajan, Raghav
    [J]. NEUROLOGY, 2021, 96 (15)
  • [27] Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
    Siddiqi, Zaeem A.
    Nowak, Richard J.
    Mozaffar, Tahseen
    O'Brien, Fanny
    Yountz, Marcus
    Patti, Francesco
    [J]. MUSCLE & NERVE, 2021, 64 (06) : 662 - 669
  • [28] Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
    Katyal, Nakul
    Narula, Naureen
    Govindarajan, Raghav
    [J]. JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (02) : 287 - 294
  • [29] Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
    Muppidi, Srikanth
    Utsugisawa, Kimiaki
    Benatar, Michael
    Murai, Hiroyuki
    Barohn, Richard J.
    Illa, Isabel
    Jacob, Saiju
    Vissing, John
    Burns, Ted M.
    Kissel, John T.
    Nowak, Richard J.
    Andersen, Henning
    Casasnovas, Carlos
    de Bleecker, Jan L.
    Vu, Tuan H.
    Mantegazza, Renato
    O'Brien, Fanny L.
    Wang, Jing Jing
    Fujita, Kenji P.
    Howard, James F., Jr.
    Kaya, Angela
    Khursigara, Gus
    Armstrong, Roisin
    Diab, Diaa
    Capocelli, Kelley
    Lane, Cindy
    Sanders, Vicky
    Gandolfo, Ruth
    [J]. MUSCLE & NERVE, 2019, 60 (01) : 14 - 24
  • [30] Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
    Brauner, Susanna
    Eriksson-Dufva, Ann
    Hietala, Max Albert
    Frisell, Thomas
    Press, Rayomand
    Piehl, Fredrik
    [J]. JAMA NEUROLOGY, 2020, 77 (08) : 974 - 981
12345